Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
So I just want to ask all of you something. What the hell are we all doing here? It's a 6 cent stock for christ's sake. You can't tell me it hasn't crossed your minds. You're all very intelligent people......well there was that one guy though.
The covid tests are all BS.
Blue Cross Blue Shield no longer providing coverage for covid tests from providers. Day by day the outlook is more bleak. Why would they cover a drug for mild to moderate risk patients who have no chance of ending up in the hospital anymore? We’ll have to rely on out of pocket coverage?
According to BMT, the Revive BOD have committed to inaction with regards to the demands of the litigious groups.
A few of the key points from the video (4 days ago)...
From Biomedical Trader (BMT)
"We have put forward an experienced executive to join the board, Dave Selkirk."
"We are aware of two groups that want to pursue legal action. I have tried to frame their demands as a win-win situation and we have received acknowledgment that the current BoD will be meeting to discuss."
"There are ways for an experienced executive to move forward even without agreement from the FDA, but these paths to revenue are not feasible without an experienced hand at the wheel."
-----------------------------------------------------------------------------------------------------------------------
Shortly ago, BMT just stated on Reddit that the BOD sent him a letter stating that he didn't need to communicate any further between the litigious groups and Revive but he's not sure what will happen next.
I think several folk’s including BMT question the Ceo leadership and strategy
When your down 90% someone should be accountable
Oh wait blame the fda. I get it
when was the photo taken?
In the Bahamas playing golf
I’m wondering all these time long where is the CEO ?
What can you do, you win some you lose some. Miracles happen, I'll stick around and see if MF can pull a rabbit out of his hat. GLTA
Man sorry to hear that.
Yes life is good even though I am down $20 grand! LOL
I’m good here! Only down $800. Made 4x that here on some tza calls today
Life is good no matter how this ends
Remember the exchange I had here with pumpers explaining why I was wrong that anyone would pay a premium???
Really dumb logic since it was fully subscribed for the $4.3M so investors did in fact "pay a premium".
Seems common sense isnt that common these days.
On another note, currently up between ~60--80% on fresh pile, even after some limited profit taking.
Laughing my arse off???.......Absolutely!!! lololsss
#plank
Laughing my ass off. Remember the exchange I had here with pumpers explaining why I was wrong that anyone would pay a premium???
One of them came back with false info that the offering was at .10. lol
Dude there’s little hope for this to get back to .15 anytime soon imho. Why??? There’s simply no catalyst
The only way it moves up to .15 or beyond is announcement of a partnership or unblinding of data showing efficacy?
DMSB recommending continuing the study also maybe but we all know they don’t have the funding or time for that
My question for this fine Tuesday morning is when and how do we get back to $.15 pps? Undoubtably we will…. based on the most recent $.15 investor offering. I imagine they intend to make more than just $.15 pps off of their investment.
Good for thought…???
I watched the podcast and appreciate the efforts of all involved. I have two thoughts:
1. I am not interested in what I believe to be frivolous lawsuits. We all knew the risks, and I still hold out hope that this can work.
2. I found the part where BMT spoke about partnerships quite interesting. He claims that negotiations are not likely due to RVVT pursuing endpoints of hospitalization when even if the data proves Bucy had none, the world has changed one and a half years later making the data antiquated. He believes that if he was guided by an outside source, a focus would have been more on symptoms for long covid. Then he mentions he may intentionally being misled so after a denial or recommendation of trial continuation by DMSB, RVVTF could be bought at a cheaper price.
He also cites that countries have a stockpile of Pax. These thoughts are troublesome.
ps. I still have hope that if we hit a wall, Bucy as a universal drug will get us back to a green pasture. I'm looking forward to unblinding to see what we have here. Also, MF will not even consider this "Chris" addition.
Recording of the shareholder meeting - Thx BMT
https://www.reddit.com/r/RVVTF/comments/12wxq58/recording_of_the_shareholder_meeting/
Thanks Bluehorse glad they recorded it I think. Wasn't able to be there busy errands etc...
https://www.reddit.com/r/RVVTF/comments/12wqfob/big_thanks_goes_out_to_bmt/?utm_source=share&utm_medium=android_app&utm_name=androidcss&utm_term=1&utm_content=share_button
Been 6 months since my last.one I'm probably at %20 lol. Probably even a little less effective against the Xbb.1.16.. Big need for Bucy if it works like the DD shows :0
How effective are BIVALENT boosters at
— Iris Gorfinkel, M.D. (@DrGorfinkel) April 21, 2023
⤵️ing HOSPITALIZATION / DEATH from
Omicron (includes XBB.1.5) ?
Disappointing findings from NEJM:
2 weeks 67 % effective
10 weeks 44 %
20 weeks 38 %
https://t.co/BgY4jC2HrX
More volume on the Canadian side lately, which is a bit rare.
I just posted a very similar comment on Stocktwits.
Biden tests everyone everywhere he goes while claiming the pandemic is over and ending the public health emergency. This is the person and team that promised us they would actually end the pandemic as thousands continue to die weekly and millions increasingly have long covid.
— Joaquín Beltrán Free Palestine (@joaquinlife) April 16, 2023
Hang in there, buddy. I've seen horses finish first without a jockey.
ps. I just realized they are disqualified, but you see my point. lol.
pps. As cash depletes, a partnership is growing more and more likely and more and more imminent.
Personally I now think of MF as the big letdown. Until he proves otherwise.
It is no good owning the best thoroughbred race horse if the Jockey is crap.
gator why not Buc for glutathione?
Glycine and NAC pair to increase Glutathione, Increased Glutathione increases have some dramatic effects on increasing life expectancy and health.
This reference cites a number of YouTube videos on the subject. Dr. Brad Stanfield is an interesting addition to the regular Youtube channels as all his videos are based souly on printed medical studies, and he has no horse in the race.
insert-text-here
Agree. This is the first time we heard it from the big cheese.
The fact that MF mentions partnership more than once in the PR is a positive sign, GLTA!
it's easy to play with percentages - but keep in mind thata 17.5% increase comes after a 66.7% decrease (just speaking roughly of the .15 to .5 drop I could site worse.
agreed I was referring to the letter. A shareholders mtg (scheduled and publicized) wouldn't be a bad idea.
Frank screwed every shareholder due to his incompetence. That’s why people are upset. And now the dsmb will likely tell them to continue which will not help anyone cause we have no money or patients, or they halt due to futility. Either way we get screwed. Not a chance they halt due to efficacy.
Maybe. But I think it is only reasonable that the shareholders can request to have a shareholders/investors call. I don't think that would have created any questionable scenarios, if the call is publicized for all to be able to join.
Just as well, they could have transcribed question & discussions, and made it available to the public. I think if they (RVV) try to use that as an out or way to possibly avoid taking questions from the "angry mob" that is just cherry picking to avoid the tough situations, which then seems to indicate a very disheartening pattern.
Did u see mice and men. We are George.
Single-Dose Psilocybin Promising for Resistant Depression
Liam Davenport
April 06, 2023
11
162
Share
Add to Email Alerts
PARIS — A single 25-mg dose of a synthetic formulation of psilocybin appears to improve the core symptoms of treatment-resistant depression (TRD), a new analysis of phase 2 trial data suggests.
Known as COMP360, the synthetic agent, a proprietary, purified form of psilocybin, improved symptoms related to mood and anhedonia while leaving aspects such as appetite and weight changes unaffected, report investigators led by Guy Goodwin, PhD, emeritus professor of psychiatry, University of Oxford, UK, and chief medical officer, COMPASS Pathways.
The study was presented here at the European Psychiatric Association (EPA) 2023 Congress.
100 Million Affected
Affecting up to 100 million people globally, TRD is "not an official diagnosis," although it is often defined as the failure to elicit a response with at least two antidepressant treatments, said Goodwin.
Compared to their counterparts with non-TRD, those with TRD experience higher relapse rates, higher rates of suicidal behavior, and more residual symptoms even when they do respond to treatment.
Previous results from the study known as P-TRD indicated that a single 25-mg dose of COMP360 significantly reduced depression scores for up to 12 weeks when given along with psychological support, although a later analysis suggested the effect subsequently dropped off.
The vast majority of the patients in the trial were naive to psychedelics, and so, Goodwin explained, they undergo a preparation phase during which they receive psychoeducation and have at least two visits with a therapist, who then stays with them during administration of the drug to offer support if they experience psychological distress.
Following the psilocybin session, participants go through a process known as integration, which involves two sessions with a therapist within 2 weeks.
Understood. It’s all good except those who do intentionally misinform
They know who they are
The PR from last night does shed light on the current conundrum MF had gotten himself into. Hopefully he resolves for all shareholders
no one here is an expert - just folks posting their views / opinions.
The FDA is in bed with big pharma and want to control everything.
According to experts here like ric this will never get approved because fda is corrupt
It’s was a pump and dump all along
If the drug has value then the only path forward is with a partnership.
Hey CW, I'm still kicking. I'm like an eagle flying above just circling this skies ever watching. Hope you are well, along with all the longtimers!
I'm thinking even IF the data shows BUC works for hospitalizations, Revive will still have difficulty getting approval based on that since it's not as pertinent as it was at the time the data was taken IF it is effective, the data should have been unblinded a year or so ago and submitted at that time. MF is now stuck between a rock and a hard place.
Boys- There is one thing that I can't get straight in my head. Well, lots of things but that is a story for another day. I get that continuing the trial is going to be tough with the current endpoints..... but.... The 710 were done with primarily the Delta Variant upon which hospitalizations were quite high and the last 500 were done with higher doses of Buccy. Even with many getting the placebo and a third getting the dosage the same as the 210, that should tell is something definitive. I guess the argument is that a few patients can swing the vote one way or another and more data would need to be collected. Any thoughts?
ps. Let's go dmsb. Ship this thing through quickly.
These PRs sound like a broken record at this point.
Probably the only way he could respond. If he sends any type of material info in a letter to just some folks and it is acted on, it's sort of insider trading. He probably tried to hit on the questions while at the same time saying he's not going to respond to individual letters / emails with anything he feels is material. True that it gave the impression of thumbing his nose at the letter, but the response had to be expected by BMT if he knows about how this stuff works.
The company don't give up easy I'll give them that
Followers
|
337
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
36642
|
Created
|
02/23/17
|
Type
|
Free
|
Moderators Classic Warrior |
Scientific Rationale of Bucillamine
Preclinical and clinical studies have demonstrated that reactive oxygen species contribute to the destruction and programmed cell death of pulmonary epithelial cells.1 N-acetyl-cysteine (NAC) has been shown to significantly attenuate clinical symptoms in respiratory viral infections in animals and humans, primarily via donation of thiols to restore antioxidant and to reduce the activity of cellular glutathione 2,3,4,5. Bucillamine (N-(mercapto-2-methylpropionyl)-l-cysteine) has a well-known safety profile and is prescribed in the treatment of rheumatoid arthritis in Japan and South Korea for over 30 years. Bucillamine, a cysteine derivative with two thiol groups, has been shown to be 16 times more potent as a thiol donor in vivo than NAC 6. The drug is non-toxic with high cellular permeability. The basis of the clinical study will analyze if Bucillamine has the potential, via restoration of glutathione activity and other anti-inflammatory activity, to lessen the negative consequences of SARS-CoV2 infection in the lungs.
| Psilocin Pharma Corp. has developed production solutions for the active compound Psilocybin. Our process encompassed with our intellectual property cover methods of production of Psilocybin based formulations. Psilocin Pharma Corp’s range of products have been engineered to work synergistically with the body's own natural pathways of absorption while offering a contemporary approach to consumption. Psilocin Pharma also has strong relationships with specific lab partners in certain areas like Brazil, where these formulations are legally approved and plan to sell products in these jurisdictions. | |
| |
Mental Health (Depression, PTSD & Anxiety)
|
Supplements for Brain Health & Cognitive Enhancement
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |